References
- Carbone E, Lux HD: A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurones. Nature 1984; 310: 501-2 https://doi.org/10.1038/310501a0
- Bertolino M, Uinas RR: The central role of voltageactivated and receptor-operated calcium channels in neuronal cells. Annu Rev Phannacol Toxicol 1992; 32: 399-421 https://doi.org/10.1146/annurev.pa.32.040192.002151
- Anwyl R: Modulation of venebrate neuronal calcium channels by transmitters. Brain Res Brain Res Rev 1991; 16: 265-81 https://doi.org/10.1016/0165-0173(91)90010-6
- Huguenard JR: Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol 1996; 58: 329-48 https://doi.org/10.1146/annurev.ph.58.030196.001553
- Carbone E. Lux AD: A low voltage-activated calcium conductance in embryonic chick sensory neurons. Biophys J 1984; 46: 413-8 https://doi.org/10.1016/S0006-3495(84)84037-0
- Chaplan SR, Pogrel JW, Yaksh TL: Role of voltagedependent calcium channel subtypes in experimental tactile allodynia. J Phannacol Exp Ther 1994; 269: 1117-23
- Matthews EA, Dickenson AH: Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal hom neuronal responses in a rat model of neuropathy. Pain 2001; 92: 235-46 https://doi.org/10.1016/S0304-3959(01)00255-X
- Dogrul A, Gardell LR, Ossipov MH, Tulunay FC, Lai J, Porreca F: Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 2003; 105: 159-68 https://doi.org/10.1016/S0304-3959(03)00177-5
-
Matthews EA, Dickenson AH: Effects of ethosuximide, a T-type
$Ca^{2+}$ channel blocker, on dorsal hom neuronal responses in rats. Eur J Phannacol 2001; 415: 141-9 https://doi.org/10.1016/S0014-2999(01)00812-3 - Kostyuk PG, Molokanova EA, Pronchuk NF, Savchenko AN. Verkhratsky AN: Different action of ethosuximide on low- and high-threshold calcium currents in rat sensory neurons. Neuroscience 1992; 51: 755-8 https://doi.org/10.1016/0306-4522(92)90515-4
- Todorovic SM, Rastogi AJ, Jevtovic-Todorovic V: Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Phannacol 2003; 140: 255-60
- Shannon HE, Eberle EL, Peters SC: Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neurophannacology 2005; 48: 1012-20 https://doi.org/10.1016/j.neuropharm.2005.01.013
-
Ertel SI, Enel EA: Low-voltage-activated T-type
$Ca^{2+}$ channels. Trends Phannacol Sci 1997; 18: 37-42 https://doi.org/10.1016/S0165-6147(96)01021-8 - Jimenez C, Bcurinet E, Leuranguer V, Richard S, Snutch TP, Nargeot 1: Determinants of voltage-dependent inactivation affect mibefradil block of calcium channels. Neuropharmacology 2000; 39: 1-10 https://doi.org/10.1016/S0028-3908(99)00153-7
- Hennsmeyer K, Mishra S, Miyagawa K, Minshall R: Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for Tctype calcium antagonists. Clin Ther 1997; 19(5uppl A): 18-26 https://doi.org/10.1016/S0149-2918(97)80034-3
- Lee DS, Goodman S, Dean DM, Lenis J , Ma P, Gervais PB, et al: Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the posicor reduction of ischemia during exercise (PRIDE) trial. Am Heart J 2002; 144: 60-7 https://doi.org/10.1067/mhj.2002.122869
- Banon ME, Eberle EL, Shannon HE: The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. Eur J Phannacol 2005; 521: 79-85 https://doi.org/10.1016/j.ejphar.2005.08.017
- Clozel JP, Ertel EA, Ertel SI: Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective Tvtype calcium channel blocker. J Hypenens Suppl 1997; 15: 17-25
-
Ertel SI, Clozel JP: Mibefradil (Ro 40-5967): the first selective T-type
$Ca^{2+}$ channel blocker. Expert Opin Investing Drugs 1997; 6: 569-82 https://doi.org/10.1517/13543784.6.5.569 - Storkson RV, Kjorsvik A, Tjolsen A, Hole K: Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosei Methods 1996; 65: 167-72 https://doi.org/10.1016/0165-0270(95)00164-6
- Brennan TJ, Vandermeulen EP, Gebhan GF: Characterization of a rat model of incisional pain. Pain 1996; 64: 493-501 https://doi.org/10.1016/0304-3959(95)01441-1
- Todorovic SM, Meyenburg A. Jevtovic-Todorovic V: Mechanical and thermal aminociccprion in rats following systemic administration of mibcfradil, a Tctype calcium channel blocker. Brain Res 2002; 951: 336-40 https://doi.org/10.1016/S0006-8993(02)03350-4
- Flatters SJ, Bennett GJ: Ethosuximide reverses paclitaxeland vincristine-induced painful peripheral neuropathy. Pain 2004; 109: 150-61 https://doi.org/10.1016/j.pain.2004.01.029
- Han HC, Lee DH, Chung JM: Characteristics of ectopic discharges in a rat neuropathic pain model. Pain 2000; 84: 253-61 https://doi.org/10.1016/S0304-3959(99)00219-5
- Liu X, Eschenfelder S, Blenk KH, lanig W, Habler H: Spontaneous activity ofaxotomized afferent neurons after L5 spinal nerve injury in rats. Pain 2000; 84: 309-18 https://doi.org/10.1016/S0304-3959(99)00211-0
- Todorovic SM, Jevtovic-Todorovic V, Meyenburg A, Mennerick S, Perez-Reyes E, Romano C. et al: Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 2001; 31: 75-85 https://doi.org/10.1016/S0896-6273(01)00338-5
- White DM, Cousins MJ: Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia. Brain Res 1998; 801: 50-8 https://doi.org/10.1016/S0006-8993(98)00539-3
- Horvath G, Brodacz B, Holzer-Petsche U: Role of calcium channels in the spinal Iransmission of nociceptive information from the mesentery. Pain 2001; 93: 35-41 https://doi.org/10.1016/S0304-3959(01)00290-1
- Diaz A, Dickenson AH: Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal hom neurones produced by subcutaneous formalin inflammation. Pain 1997; 69: 93-100 https://doi.org/10.1016/S0304-3959(96)03271-X
- Smith MT, Cabot PJ, Ross FB, Robertson AD, Lewis RJ: The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 2002; 96: 119-27 https://doi.org/10.1016/S0304-3959(01)00436-5